Jay Kolls, MD

Jay Kolls, MD

Professor of Medicine & Pediatrics, John W Deming Endowed Chair in Internal Medicine

Mylab is interested in immunology and inflammation with a particular interest inCD4+ T cells including regulatory T cells and Th17 cells that have beenimplicated in cancer.  My lab hasextensively used RNAseq and single cell sequencing to study T –cells duringinflammation and how they signal to neighboring tissues.  We established the CTRII NGS core in 2017 ( https://medicine.tulane.edu/centers-institutes/tulane-center-translational-research-infection-inflammation) which supports single cell chemistriesacross the Tulane Campus.  We also havean interest in immunotherapy using cytokines or CAR-T cells.   I can contribute my expertise in immunologyas well as expertise in single cell genomics. My lab has partnered with other labs on head and neck cancer, lungcancer as well as mesothelioma.  I havealso been MPI on a P30 grant as lead of a NGS core.  

Education:

     
  • BS, Physics, Ursinus College, 1981
  •  
  • MD, University of Maryland, 1985
  •  
  • Residency in Medicine/Pediatrics, LSU/Charity: 1985-1989
  •  
  • Adult Pulmonary Fellowship LSUHSC, 1989-1993
  •  
  • Pediatric Pulmonary Fellowship, Tulane School of Medicine,      1989-1993
  •  
  • Post-Doctoral Research Fellow, lab of Dr. Bruce Beutler, Nobel      Laureate 2011, 1992-1993

ORCID identifier: 0000-0001-5151-6304

https://www.ncbi.nlm.nih.gov/myncbi/jay.kolls.1/bibliography/public/

Selected Publications:

 

W Ouyang, JKKolls, Y Zheng The biological functions of T helper 17 cell effector cytokinesin inflammation. Immunity 28 (4), 454-467         2137,2008

 

P Ye, FHRodriguez, S Kanaly, KL Stocking, J Schurr, P Schwarzenberger, et. al.

Requirement ofinterleukin 17 receptor signaling for lung CXC chemokine and granulocytecolony-stimulating factor expression, neutrophil recruitment, and host defense.The Journal of Experimental Eedicine 194 (4), 519-528,     2001

 

SJ Aujla, YRChan, M Zheng, M Fei, DJ Askew, DA Pociask, TA Reinhart, et. al. IL-22 mediatesmucosal host defense against Gram-negative bacterial pneumonia

Nature medicine14 (3), 275-281, 2008

 

A Cossarizza, HDChang, A Radbruch, A Acs, D Adam, S Adam‐Klages, et. al. Guidelinesfor the use of flow cytometry and cell sorting in immunological studies. Europeanjournal of immunology 49 (10), 1457-1973       1405    2019

 

 

P Miossec, JKKolls Targeting IL-17 and TH17 cells in chronic inflammation

Nature reviewsDrug discovery 11 (10), 763-776

 

Iwanaga N, ChenK, Yang H, Lu S, Hoffmann JP, Wanek A, McCombs JE, Song K, Rangel-Moreno J,Norton EB, Kolls JK. Vaccine-driven lung TRM cells provide immunity againstKlebsiella via fibroblast IL-17R signaling. Sci Immunol. 2021 Sep 10;6(63).

 

 

Keywords/Tags: Th17 cells, single cell RNAseq, T cell immunology, gene therapy

https://medicine.tulane.edu/centers-institutes/tulane-center-translational-research-infection-inflammation

LCRC Faculty

Jayalakshmi Sridhar PhD
Translational Oncology
Xavier University
Shang Su, Phd
Cancer Biology
LSU School of Veterinary Medicine
Kevin Sullivan, MD
Cancer Biology
LSU Health - New Orleans
Gulshan Sunavala-Dossabhoy, PhD
Translational Oncology
LSU Health - New Orleans
Paul Sylvester PhD
Cancer Biology
University of Louisiana Monroe
Xiaochao Tan, PhD
Cancer Biology
Tulane University School of Medicine
Paul Thevenot, PhD
Translational Oncology
Ochsner Health
Raju Thomas MD
Translational Oncology
Tulane University School of Medicine
Aiguo Tian PhD
Cancer Biology
Tulane University School of Medicine